Sickle cell skepticism

2:15 PM ET Mon, 7 Dec 2015

CNBC's Meg Tirrell talks to the CEO of Global Blood Therapeutics, which has been hit today after disappointing data from its new sickle cell treatment. CEO Ted Love explains what's next for the company.